Showing results (251-260 of 1,348) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|June 4, 2020
Phase 1 Study to Evaluate the Effect of the Investigational Anticancer Agent Sapanisertib on the QTc Interval in Patients With Advanced Solid TumorsChirag Patel, Sanjay Goel, Manish R Patel, et al.Clinical Pharmacology in Drug Development|July 11, 2025
Pharmacokinetic and Bioequivalence Evaluation of Two Sitagliptin Tablets With Different Salts in Healthy SubjectsUsok Hyun, Seongnam Chu, Sungyun Kim, et al.Clinical Pharmacology in Drug Development|July 4, 2025
Pharmacokinetics and Safety of Armodafinil in Chinese Healthy Humans After Multiple-Dose Oral AdministrationLiwei Lang, Yuan Dong, Zhenzhen Zhu, et al.Clinical Pharmacology in Drug Development|July 3, 2025
Pharmacokinetics and Bioequivalence Evaluation of Two Different Aildenafil Citrate Tablet Formulations in Healthy Chinese Male Subjects Under Fasting and Fed ConditionsHegui Yan, Yu Peng, Zhixiang Pan, et al.Clinical Pharmacology in Drug Development|January 31, 2025
Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Subcutaneous Rusfertide, a Hepcidin Mimetic, in Healthy SubjectsNishit B Modi, Phillip Dinh, Ifode AjariClinical Pharmacology in Drug Development|January 16, 2025
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult SubjectsShamia L Faison, Joelle Batonga, Thangam Arumugham, et al.Clinical Pharmacology in Drug Development|January 3, 2025
Clinical Pharmacology and Approach to Dose Selection of Emestedastat, a Novel Tissue Cortisol Synthesis Inhibitor for the Treatment of Central Nervous System DiseasePaul Rolan, Jonathan Seckl, Jack Taylor, et al.Clinical Pharmacology in Drug Development|January 20, 2025
Bioequivalence and Food Effect Assessment Between 2 Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Chinese SubjectsKaixian Tang, Yingrong Chen, Jue Mei, et al.Clinical Pharmacology in Drug Development|December 9, 2024
A Phase 1 Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone TherapyRandolph P Matthews, Wendy Ankrom, Whitney Handy, et al.Clinical Pharmacology in Drug Development|September 4, 2024
Safety and Pharmacokinetics of Single-Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 StudyJunyu Xu, Ran Xie, Yongjia Ji, et al.Pageof 135